Bernd Seizinger

Directeur/Membre du Conseil chez APREA THERAPEUTICS, INC. Fortune : 955 645 $ au 30/06/2026

Profil

Bernd Robert Seizinger is the founder of CryptoMedix, Inc., founded in 2015, where the title held is Executive Chairman & Chief Executive Officer.
Current jobs include Independent Director at Oncolytics Biotech, Inc. since 2015; Director at Oxford BioTherapeutics Ltd. since 2016; Independent Director at BioInvent International AB since 2018; Director at Karolinska Institutet; Director at Aprea Therapeutics AB since 2015; Director at TriMod Therapeutics Ltd. since 2011; Independent Director at Aprea Therapeutics, Inc. since 2015; Independent Director at Turbine Simulated Cell Technologies Ltd. since 2023.
Former jobs include President & Chief Executive Officer at GPC Biotech AG from 1998 to 2009; Director at Nykode Therapeutics ASA from 2014 to 2024; Independent Director at BioXell SpA from 2010 to 2012; Director-Molecular Neuro-Oncology Laboratory at The General Hospital Corp.
in 1992; Director at Santhera Pharmaceuticals Holding AG from 2004 to 2011; Non-Executive Director at Bionor Pharma ASA; Independent Director at Aptose Biosciences, Inc. from 2022 to 2026; Chief Scientific Officer & Executive VP at Oscient Pharmaceuticals Corp.; Principal at Princeton University; VP-Oncology Drug Discovery & Academic Alliances at Bristol-Myers Squibb Pharmaceutical Research Institute from 1992 to 1996; Associate Professor-Neuroscience at Harvard Medical School in 1992; Member-Supervisory Board at Agennix AG.
Education includes doctorate degrees from Max-Planck-Institute for Molecular Genetics and Ludwig-Maximilians-Universität München.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ONCOLYTICS BIOTECH INC. 0,48 %	01/06/2026	566 991 ( 0,48 % )	538 641 $	30/06/2026
NYKODE THERAPEUTICS ASA 0,2 %	31/12/2024	650 000 ( 0,2 % )	211 510 $	30/06/2026
BIOINVENT INTERNATIONAL AB 0,1 %	31/12/2025	66 000 ( 0,1 % )	168 782 $	30/06/2026
APREA THERAPEUTICS, INC. 0,37 %	16/06/2026	45 775 ( 0,37 % )	36 712 $	30/06/2026

Postes actifs de Bernd Seizinger

Sociétés	Poste	Début
ONCOLYTICS BIOTECH INC.	Directeur/Membre du Conseil	08/06/2015
BIOINVENT INTERNATIONAL AB	Directeur/Membre du Conseil	01/01/2018
APREA THERAPEUTICS, INC.	Directeur/Membre du Conseil	01/01/2015
CryptoMedix, Inc.	Directeur Général	-
Oxford BioTherapeutics Ltd.	Directeur/Membre du Conseil	14/12/2016
Karolinska Institutet	Directeur/Membre du Conseil	-
Aprea Therapeutics AB	Directeur/Membre du Conseil	01/01/2015
TriMod Therapeutics Ltd.	Directeur/Membre du Conseil	01/11/2011
Turbine Simulated Cell Technologies Ltd.	Directeur/Membre du Conseil	20/06/2023

Anciens postes connus de Bernd Seizinger

Sociétés	Poste	Fin
░░░░░░ ░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░ ░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░